Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Zhixiang Zuo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2492-2689; OpenAlex author ID A5090129059. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: 2 papers

Papers 6

  1. CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. Last author DOI 10.1038/s41467-023-41861-y↗
  2. Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41588-023-01568-8↗
  3. LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling. Co-author DOI 10.1038/s41467-021-23904-4↗
  4. Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. Co-author DOI 10.1186/s13073-021-01002-w↗
  5. The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fcell.2021.821232↗
  6. Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Co-author DOI 10.1038/s41467-019-09712-x↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Zheng · 5 shared papers, 2019–2023 · strength 0.55
  2. Jiachun Su · 5 shared papers, 2019–2023 · strength 0.55
  3. Jialiang Zhang · 5 shared papers, 2019–2023 · strength 0.55
  4. Dongxin Lin · 5 shared papers, 2019–2023 · strength 0.55
  5. Xudong Huang · 4 shared papers, 2021–2023 · strength 0.48
  6. Rufu Chen · 4 shared papers, 2019–2023 · strength 0.41
  7. Yanfen Zheng · 4 shared papers, 2019–2023 · strength 0.40
  8. Ying Ye · 4 shared papers, 2019–2023 · strength 0.40
  9. Rui Li · 3 shared papers, 2021–2023 · strength 0.38
  10. Lingxing Zeng · 3 shared papers, 2021–2023 · strength 0.38
  11. Shaoping Zhang · 3 shared papers, 2021–2023 · strength 0.38
  12. Quanbo Zhou · 2 shared papers, 2023 · strength 0.28
  13. Ling Pan · 3 shared papers, 2019–2021 · strength 0.26
  14. Lusheng Wei · 2 shared papers, 2021 · strength 0.20
  15. Junge Deng · 2 shared papers, 2021 · strength 0.20
  16. Xu Che · 2 shared papers, 2019–2021 · strength 0.16
  17. Chen Hsuan Wu · 2 shared papers, 2019–2021 · strength 0.16
  18. Chengfeng Wang · 2 shared papers, 2019–2021 · strength 0.16
  19. Xuefei Liu · 1 shared paper, 2021 · strength 0.15
  20. Xuechen Ren · 1 shared paper, 2021 · strength 0.15
  21. Rufu Chen · 1 shared paper, 2023 · strength 0.14
  22. Guandi Wu · 1 shared paper, 2021 · strength 0.10
  23. Zhiqiang Fu · 1 shared paper, 2019 · strength 0.07
  24. Shengping Li · 1 shared paper, 2019 · strength 0.07
  25. Guolin Li · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.